R1	Has_value Arg1:T1 Arg2:T2	
R2	Has_qualifier Arg1:T6 Arg2:T5	
R3	Has_qualifier Arg1:T6 Arg2:T4	
R4	Has_temporal Arg1:T7 Arg2:T8	
R5	AND Arg1:T11 Arg2:T10	
R6	Has_temporal Arg1:T11 Arg2:T12	
R7	Has_index Arg1:T12 Arg2:T13	
R8	Has_qualifier Arg1:T16 Arg2:T15	
R9	Has_multiplier Arg1:T16 Arg2:T14	
R10	AND Arg1:T17 Arg2:T16	
R11	AND Arg1:T17 Arg2:T18	
R12	AND Arg1:T21 Arg2:T20	
T1	Person 0 3	Age
T2	Value 7 17	= 18 years
T3	Observation 29 66	able to give written informed consent
T4	Qualifier 69 75	Active
T5	Qualifier 76 83	chronic
T6	Condition 84 123	central serous chorioretinopathy (cCSC)
T7	Condition 126 148	Subjective visual loss
T8	Temporal 149 158	> 6 weeks
T9	Non-representable 160 199	interpreted as onset of active disease;
T10	Condition 201 230	Foveal subretinal fluid (SRF)
T11	Procedure 235 269	optical coherence tomography (OCT)
T12	Temporal 271 294	at Baseline Examination
T13	Reference_point 274 294	Baseline Examination
T14	Multiplier 297 299	=1
T15	Qualifier 300 311	ill-defined
T16	Condition 312 342	hyperfluorescent leakage areas
T17	Procedure 346 374	fluorescein angiography (FA)
T18	Condition 380 423	retinal pigment epithelial window defect(s)
T19	Non-representable 424 453	that are compatible with cCSC
T20	Condition 456 478	Hyperfluorescent areas
T21	Procedure 482 518	indocyanine green angiography (ICGA)
